Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
J Thorac Cardiovasc Surg. 2015 Jan;149(1):230-6. doi: 10.1016/j.jtcvs.2013.11.040. Epub 2013 Dec 31.
Acute kidney injury (AKI) is common in infants after cardiopulmonary bypass and is associated with poor outcomes. Peritoneal dialysis improves outcomes in adults with AKI after bypass, but pediatric data are limited. This retrospective case-matched study was conducted to determine if the practice of peritoneal dialysis catheter (PDC) placement during congenital heart surgery is associated with improved clinical outcomes in infants at high risk for AKI.
Forty-two infants undergoing congenital heart surgery with planned PDC placement (PDC+) were age-matched to infants undergoing similar surgery without PDC placement (PDC-). Demographic, baseline and outcome data were compared. Our primary outcome was negative fluid balance on postoperative days 1 to 3. Secondary outcomes included time to negative fluid balance, time to extubation, frequency of electrolyte corrective medications, inotrope scores, and other clinical outcomes.
Baseline data did not differ between groups. The PDC+ group had a higher percentage of negative fluid balance on postoperative days 1 and 2 (57% vs 33%, P = .04; 85% vs 61%, P = .01). The PDC+ group had shorter time to negative fluid balance (16 vs 32 hours, P < .0001), earlier extubation (80 vs 104 hours, P = .02), improved inotrope scores (P = .04), and fewer electrolyte imbalances requiring correction (P = .03). PDC-related complications were rare.
PDC use is safe and associated with earlier negative fluid balance and improved clinical outcomes in infants at high risk for AKI. Routine PDC use should be considered for infants undergoing cardiopulmonary bypass. Further prospective studies are essential to prove causative effects of PDC placement in this population.
体外循环后婴儿急性肾损伤(AKI)很常见,与不良预后相关。腹膜透析可改善体外循环后成人 AKI 的预后,但儿科数据有限。本回顾性病例匹配研究旨在确定在先天性心脏病手术中放置腹膜透析导管(PDC)是否与高危 AKI 婴儿的临床结局改善相关。
42 例计划行 PDC 放置(PDC+)的先天性心脏病手术婴儿与未行 PDC 放置(PDC-)的类似手术婴儿进行年龄匹配。比较人口统计学、基线和结局数据。我们的主要结局是术后 1 至 3 天的负平衡液体。次要结局包括负平衡液体时间、拔管时间、电解质纠正药物的频率、儿茶酚胺评分和其他临床结局。
两组基线数据无差异。PDC+组术后第 1 天和第 2 天的负平衡液体百分比更高(57% vs 33%,P=0.04;85% vs 61%,P=0.01)。PDC+组达到负平衡液体的时间更短(16 小时 vs 32 小时,P<0.0001),拔管时间更早(80 小时 vs 104 小时,P=0.02),儿茶酚胺评分改善(P=0.04),需要纠正的电解质失衡更少(P=0.03)。PDC 相关并发症罕见。
PDC 使用安全,并与高危 AKI 婴儿的早期负平衡液体和临床结局改善相关。应考虑在接受体外循环的婴儿中常规使用 PDC。进一步的前瞻性研究对于证明该人群中 PDC 放置的因果关系至关重要。